Webcast Teaches Physicians About Advances in Liver Disease

OSU Wexner Medical Center logo Webcast Teaches Physicians About Advances in Liver Disease. Last summer, experts from around the world worked together to rename Nonalcoholic fatty liver disease into Metabolic dysfunction-associated steatotic liver disease or MASLD. And earlier this year at the end of March 2024, the FDA approved the first drug to treat MASLD. Meanwhile another promising agent is already in the pipeline, currently undergoing phase 3 clinical trials.

To share more about the advances in some of the most common liver conditions including MASLD, autoimmune hepatitis, and Hepatocellular carcinoma, We’ve invited one of Ohio State University’s Transplant Hepatology experts. We are pleased to introduce Assistant Professor of Gastroenterology and Hepatology Dr Vivek Mendiratta.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand steatotic liver disease including diagnosis, management, and pharmacologic treatment options.
  • Learn about the newest advances in hepatocellular carcinoma including the role of combination therapy, novel biomarkers, and liver transplantation.

You’ll also learn about the following:

  • Treatment & Monitoring
  • Weight Loss
  • Liver Transplantation

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches About Managing Complications of Chemotherapy

OSU Wexner Medical Center logo CME Webcast Teaches About Managing Complications of Chemotherapy. With more and more patients being exposed to cancer treatments, it is important for us to be familiar with the side effects and toxicities of modern chemotherapy agents. May is National Cancer Research Month. For today’s topic, We’ve invited one of Ohio State University James cancer hospitals Oncology experts. On this webcast, we get to welcome Associate Professor of Oncology Dr Edmund Folefac, who specializes in treating genitourinary cancers. In addition he is widely published cancer researcher.

What you’ll learn in this webcast

  • As a result of this educational activity, webcast participants will be able to:
  • Become familiar with common adverse reactions of newer chemotherapy agents including tyrosine kinase inhibitors, immunotherapy, and antibody drug conjugates.

Understand the basic principles of treating mild, moderate and severe toxicities to chemotherapy.

You’ll also learn about the following:

  • Evolution of Cancer Therapies
  • Red Flags
  • General Wellness
  • Long Term Therapy

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease

OSU Wexner Medical Center logo

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease. There is no cure for Parkinson’s disease. Yet, there is reason for hope. In recent years, groundbreaking research has propelled us closer to understanding the underlying mechanisms of the condition and developing more effective treatments. From deep brain stimulation to innovative pharmacological interventions, the future of Parkinson’s care is brighter than ever before.

To discuss the new developments in Parkinson’s Disease care, we’ve have invited an expert from Ohio State University Wexner Medical Center’s Center for Parkinson’s Disease. We are pleased to introduce Assistant Professor of Neurology Dr. Zachary Jordan. Zach is fellowship trained in movement disorders and specializes in the care of Parkinson’s Disease.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the basic approach to medical management of motor symptoms in Parkinson’s disease
  • Recognize motor complications and the strategies that exist to address them

You’ll also learn about the following:

  • Prevalence
  • Prognosis
  • Dosing
  • Adjuvant Therapies
  • Advance Care Planning
  • Treatment Side Effects
  • Cognitive Dysfunction
You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Expert Teaches on Benign Hair and Nail Disorders

OSU Wexner Medical Center logo Expert Teaches on Benign Hair and Nail Disorders. To discuss common benign hair and nail conditions today, We’ve invited one of Ohio State University’s Dermatology experts. We’re pleased to introduce Assistant Professor of Dermatology Dr Stephanie Trovato. Not only is Stephanie a board certified Dermatologist, but she also specializes in hair loss and scalp disorders.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Identify benign hair/nail disorders
  • Discuss common findings of benign hair/nail disorders

You’ll also learn about the following:

  • Direct to Consumer Products
  • Manicures

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on The Dizzy Patient

OSU Wexner Medical Center logo CME Webcast Teaches on The Dizzy Patient. On this webcast, we’ll be discussing the approach to a dizzy patient. For this, we’ve invited two vestibular experts. Dr. Desi Schoo is an otolaryngologist and physician-scientist at the Ohio State University Wexner Medical Center specializing in vestibular dysfunction and cranial base surgeries. He will lead us through a review of the vestibular system and approach to a patient with complaints of dizziness including advanced diagnostic testing and management. Matthew Bjelac is a board certified Neurologic physical therapist at Ohio State and vestibular team lead. Matt will discuss physical exam and screening tests as well as vestibular rehabilitation.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Gain familiarity with collecting a thorough history for dizzy patients and recognize when to refer to a specialist
  • Review common bedside and laboratory-based tests of vestibular function
  • Perform a bedside exam to identify common mechanisms of dizziness and imbalance.
  • Demonstrate the clinical reasoning to identify and treat benign positional paroxysmal vertigo (BPPV) to model CPG action statements and recommended best practice patterns for treating positional vertigo.

You’ll also learn about the following:

  • Dizziness vs Vertigo vs Imbalance
  • Vestibular Rehabilitation
  • Nystagmus

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.